Interactions between hematopoietic growth factors: the clinical role of combination biotherapy.
Moore
M A
MA
James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D003115:Colony-Stimulating Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D016179:Granulocyte Colony-Stimulating Factor; D006801:Humans; D007375:Interleukin-1 / Q000008:administration & dosage / Q000627:therapeutic use*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D011837:Radiation-Protective Agents
D003115:Colony-Stimulating Factors; D007375:Interleukin-1; D011837:Radiation-Protective Agents; D016179:Granulocyte Colony-Stimulating Factor